Skip to main content

Moderna testing 2 booster shots to protect against Omicron variant, expects data soon

US-based pharmaceutical giant Moderna is studying two booster shot options designed to anticipate mutations similar to the Omicron strain of the coronavirus, which has been designated as a variant of concern by the WHO.

It is already working to test the ability of the current vaccine dose to neutralise the Omicron variant and data is expected in the coming weeks.

“Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant,” the company said in a statement.

The first candidate (mRNA-1273.211) includes several mutations present in the Omicron variant that were also present in the Beta variant of concern1. Moderna said it has completed dosing in a potentially pivotal safety and immunogenicity study of mRNA-1273.211 at the 50 µg (N=300) and 100 µg (N=584) dose levels.

ALSO READ | PM Modi chairs key meet on Covid-19, vaccination status amid concerns over Omicron variant

A second multi-valent candidate (mRNA-1273.213) includes many of the mutations present in the Omicron variant that were also present in the Beta and Delta variants2. The company has completed dosing at the 100 µg (N=584) dose level and also plans to explore the 50 µg dose level in approximately 584 participants.

Moderna said it will “rapidly advance” an Omicron-specific booster shot, much like its Beta- and Delta-specific boosters.

“A booster dose of an authorised vaccine represents the only currently available strategy for boosting waning immunity,” the company said.

The new coronavirus variant B.1.1.529, dubbed Omicron, was first reported to the WHO from South Africa on November 24, and has also been identified in Botswana, Belgium, Hong Kong and Israel.

ALSO READ | WHO names new Covid variant Omicron; South Africa says travel bans unjustified | Top points

Global authorities have reacted with alarm to the new variant, with the United States, UK and the EU among those tightening border controls as scientists sought to find out if the mutation was vaccine-resistant.

Pfizer and BioNTech said they expect more data on the Omicron strain to determine whether its Covid-19 vaccine would have to be reworked. Johnson and Johnson also said it is closely monitoring emerging strains of coronavirus and is testing the effectiveness of its shot against the new variant.

(With inputs from Agencies)

Comments

Post a Comment

Popular posts from this blog

Siddhant will be questioned about the data received from CCTV mobile, asked to appear within 7 days

The Bangalore Police has issued summons to Bollywood actress Shraddha Kapoor’s brother and Shakti Kapoor’s son Siddhant Kapoor for taking drugs. According to media reports, the summon has been issued on Tuesday and within 7 days, Siddhant is to appear before the Investigative Officer of Bangalore Police. The police want to interrogate him about the verification of CCTV footage as well as the data taken from his mobile. What is the whole matter? Inquiry is going on into the case of taking drugs from Siddhant. Last month, his blood test came positive along with four others at a party. A total of 35 people attended the party. Everyone’s blood test was done. Tests of five people, including Siddhant, indicated that they had taken drugs. Siddhant has also been arrested in this case. He is on bail now. According to media reports, Siddhant had told the police that one man had given him a drink and another had given him a cigarette. They don’t know how the drugs got into ...
Post a Comment
Read more

Ayushmann Khurrana’s film ‘Doctor Ji’ gets ‘A’ certification, makers happy

Ayushmann Khurrana starrer ‘Doctor Ji’ has got an ‘A’ certificate from the censor board and the filmmakers are happy that there is no cut in the film. ‘Doctor Zee’ features Ayushmann playing the role of a gynecologist in a medical campus comedy-drama. This is the journey of an aspiring orthopedic surgeon who studies gynecology. Being the only man in the female-dominated department begins his struggle to fit in. This season of Bigg Boss was hosted by Big B, and Amitabh Bachchan appeared in these TV shows. Amrita Pandey, the CEO, of Junglee Pictures, said, “The film is bold, full of entertainment, yet subtly breaks stereotypes as one might expect from a true Ayushmann Khurrana film.” Rahul Dev Burman was roaming with Shailendra all night for a song, and knows an interesting story related to him “We are glad that no scenes have been cut in the film and we are able to present the film in theatres, that too in less than 2 hours, Doctor Ji will ...
Post a Comment
Read more

Bollywood Wrap: ‘Kaun Banega Crorepati’ got off to a great start, Taapsee Pannu attacks Karan Johar

Bollywood Wrap: B-Town buffs are eagerly waiting for every update on the personal and professional life of their favorite stars. He is always desperate to catch a glimpse of his stars. Keeping a close eye on B-Town is also important because something new is happening here every moment. So let us tell you what is happening in the world of stars today. Let’s know the 5 big news of the day today from the world of entertainment … Koffee With Karan 7 Karan Johar’s chat show ‘Koffee With Karan 7’ is constantly making headlines. But in the meantime, Taapsee Pannu has also taken a jibe at Karan’s show. Taapsee Pannu’s film ‘Dobaara’ is going to release soon. For which the actress is also promoting fiercely. During the promotion, the actress questioned about Karan’s show. Taapsee Pannu on not being invited to ‘Koffee With Karan 7’ says her sex life is not interesting enough to be invited to ‘Koffee with Karan’. T...
Post a Comment
Read more